Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Polycystic ovary syndrome (PCOS) is a common endocrinopathy characterized by increased ovarian androgen biosynthesis, anovulation, and infertility. PCOS has a strong heritable component based on familial clustering and twin studies. Genome-wide association studies (GWAS) identified several PCOS candidate loci including LHCGR, FSHR, ZNF217, YAP1, INSR, RAB5B, and C9orf3. We review the functional roles of strong PCOS candidate loci focusing on FSHR, LHCGR, INSR, and DENND1A. We propose that these candidates comprise a hierarchical signaling network by which DENND1A, LHCGR, INSR, RAB5B, adapter proteins, and associated downstream signaling cascades converge to regulate theca cell androgen biosynthesis. Future elucidation of the functional gene networks predicted by the PCOS GWAS will result in new diagnostic and therapeutic approaches for women with PCOS.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346470 | PMC |
| http://dx.doi.org/10.1016/j.tem.2014.12.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Impact of Age at First Sexual Intercourse on Female Reproductive Disorders: A Mendelian Randomized Study.
Int J Womens Health
September 2025
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, People's Republic of China.
Background: Female reproductive disorders (FRDs) are common diseases among women of childbearing age, affecting their reproductive health. Age at first sexual intercourse (AFS) is potentially linked to FRDs, and this study aims to investigate these associations and underlying mechanisms, to offer new insights and guidance for sex education in adolescent women and reproductive health management.
Methods: Mendelian randomization (MR) analysis was performed using summary data from genome-wide association studies (GWASs).
Genetics of Polycystic Ovary Syndrome (PCOS).
Reproduction
August 2025
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Polycystic ovary syndrome (PCOS) is a common and heterogeneous disorder currently diagnosed only in reproductive-age women. Familial clustering and twin studies have provided strong evidence for a genetic contribution to PCOS pathogenesis. First-degree relatives, including males and non-reproductive-age females, have reproductive and metabolic phenotypes consistent with a genetic susceptibility to these traits.
View Article and Find Full Text PDFDeciphering polycystic ovary syndrome: A brief overview from metabolic drivers to genetic and fetal origins.
Rev Invest Clin
August 2025
Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, CDMX, 14080 Mexico, Mexico. Electronic address:
Polycystic ovary syndrome (PCOS) is a multifactorial endocrine and metabolic disorder in women of reproductive age characterized by hormonal imbalances, menstrual irregularities, and changes in ovarian morphology. Excess body fat plays a significant role in the clinical development of PCOS. The complex relationship between adiposity and PCOS involves disruptions in hormonal balance and inflammatory processes, which both contribute to the clinical and phenotypic manifestations of the syndrome.
View Article and Find Full Text PDFGene regulatory activity associated with polycystic ovary syndrome revealed DENND1A-dependent testosterone production.
Nat Commun
August 2025
University Program in Genetics and Genomics, Duke University, Durham, NC, USA.
Polycystic ovary syndrome (PCOS) is among the most common disorders affecting up to 15% of the menstruating population globally. It is the leading cause of anovulatory infertility and a major risk factor for type 2 diabetes. Elevated testosterone levels are a core endophenotype.
View Article and Find Full Text PDFExploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study.
Brain Behav
August 2025
Department of Endocrinology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Background: Evidence concerning the causal effects of blood metabolites on polycystic ovary syndrome (PCOS) risk remains scarce. A two-sample Mendelian randomization (MR) analysis was performed among individuals of European ancestry to establish a causal relationship between plasma metabolites and the risk of PCOS.
Objective: To determine causal associations between 1400 blood metabolites and PCOS.